Tert-Butylhydroquinone Alleviates Hepatic Ischemia Reperfusion Injury in Rats Through Nrf2 Pathway

Xianpeng ZENG,Xiaojing LI,Qiuyan ZHANG,Zehong FANG,Wenjin LIANG,Ling LI,Yan XIONG,Yanfeng WANG,Qifa YE
DOI: https://doi.org/10.14188/j.1671-8852.2017.06.006
2017-01-01
Abstract:Objective:To explore the protective function of tert-butylhydroquinone (tBHQ) on rat liver ischemia-reperfusion injury and its mechanism.Methods:Twenty-four adult male rats were randomly divided into four groups:@SHAM+DMSO group(SD);② Ischemia reperfusion injury (IRI) +DMSO group(ID);③SHAM+tBHQ group(ST);④IRI+tBHQ group(IT).The tBHQ were administrated into rats at intervals of 12 h by three tail vein injections.Western blot analysis and lluorescence quantitative PCR were used to examine protein expression of Nrf2,HO-1 and ARE,respectively.The concentration of MDA and SOD activity were determined,and the degree of liver injury was tested by HE.Results:Compared with those in SD group,AST,ALT,Nrf2 expression and MDA content were significantly raised in ID group,while SOD activity was dramatically declined.Meanwhile,in IT group,tBHQ alleviated hepatocellular damage,promoted NQO1,GSTs and GCL expression,and regained redox homeostasis in comparison with ID group.Conclusion:TBHQ exerted effective antioxidant effects on hepatic IRI,and tBHQ would be a new potential therapeutic measure for preventing hepatic IRI during liver surgery.
What problem does this paper attempt to address?